U.S. markets closed
  • S&P 500

    4,119.21
    +42.61 (+1.05%)
     
  • Dow 30

    34,092.96
    +6.92 (+0.02%)
     
  • Nasdaq

    11,816.32
    +231.77 (+2.00%)
     
  • Russell 2000

    1,960.81
    +28.87 (+1.49%)
     
  • Crude Oil

    76.91
    +0.50 (+0.65%)
     
  • Gold

    1,970.80
    +28.00 (+1.44%)
     
  • Silver

    24.17
    +0.56 (+2.38%)
     
  • EUR/USD

    1.1017
    +0.0151 (+1.39%)
     
  • 10-Yr Bond

    3.3970
    -0.1320 (-3.74%)
     
  • GBP/USD

    1.2390
    +0.0074 (+0.60%)
     
  • USD/JPY

    128.6530
    -1.4150 (-1.09%)
     
  • BTC-USD

    23,763.96
    +638.79 (+2.76%)
     
  • CMC Crypto 200

    538.70
    +296.03 (+121.98%)
     
  • FTSE 100

    7,761.11
    -10.59 (-0.14%)
     
  • Nikkei 225

    27,346.88
    +19.77 (+0.07%)
     

Biogen Stock Slumps On Report of Death in Alzheimer's Drug Trial

Biogen Stock Slumps On Report of Death in Alzheimer's Drug Trial

Science.org reported Sunday that a woman participating in the joint Bigoen-Eisai Clarity AD trial of an experimental Alzheimer's treatment has died of a brain hemorrhage.